from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1671/-

LFCtreatmentdescriptionclass of inhibitor

0.745

Amikacinug/mL Amikacintranslation

0.177

Cap5-10ug/mL Capreomycintranslation

0.989

Rox10-50 ug/mL Roxithromycintranslation

-0.364

SM2-5 ug/mL Streptomycintranslation

1.483

Tet5-10 ug/mL Tetracyclinetranslation

-0.605

Rif0.2-5ug/mL Rifampicintranscription

-0.064

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.162

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.883

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.242

CPZ10-50 ug/mL Chlorpromazinerespiration

0.807

Clofazimine10-13 ug/mL Clofaziminerespiration

0.171

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.050

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.389

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.586

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.012

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.326

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.046

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.206

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.718

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.034

KCN5-20 ug/mL Potassium cyaniderespiration

-0.177

NaN30.2-2 mM Sodium aziderespiration

-1.055

Nigericin50 uM Nigericinrespiration

0.142

TRC10-150 ug/mL Triclosanrespiration

1.613

TRZ10-25 ug/mL Thioridazinerespiration

1.345

Valinomycin0.5-10 uM Valinomycinrespiration

-1.719

ZnSO42 mM ZnSO4respiration

-1.002

menadione6-10 ug/mL Menadionerespiration

0.348

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.890

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.042

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.874

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.323

NRP_1Non-replicating persistence stage 1dosRassociated

-0.482

Amp0.2mg/mL AmpicillincellWall

-0.201

Cephalexin20-100 ug/mL CephalexincellWall

-0.882

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.070

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.276

EMB10-20 ug/mL EthambutolcellWall

-0.500

Eta12-40 ug/mL EthionamidecellWall

-0.163

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.508

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.489

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.077

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.554

BZA0.12 mg/mL BenzamidearomaticAmides

-0.351

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.051

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.772

H2O24 mM hydrogen peroxideDNAdamaging

-0.355

Levo10 ug/mL LevofloxacinDNAdamaging

-0.284

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.180

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.342

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.413

UVUV-irradiationDNAdamaging

0.890

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.198

Antimycin12.5-50 ug/mL Antimycin A?

-1.736

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.234

PA_110-50 ug/mL Antitubercular compound PA-1?

0.305

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.349

PA8240.2-2 ug/mL PA-824?

1.117

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.215

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.009

Verapamil50 uM Verapamil?

-1.397

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.940

methoxatin10-20 ug/mL Methoxatin?